R & d - cell-based wound therapeutics
Ended Definitive Contract Awarded Last action
- Contract number
- N6264513C4014
- Awardee
-
Noveome Biotherapeutics Inc. UEI D35WXDLB8K59
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $53,076,259
Award facts
- Opportunity
-
- Research that uses amnion-derived multi-potent progenitor cells and their secreted cytokine solution to decrease loss of tissue, obtain more rapid wound closure, and decrease scarring in support of the Naval Medical Research Center, Silver Spring, MD Award Notice · Posted Sep 7, 2016
- Research that uses Amnion-derived multi-potent progenitor cells and their secreted cytokine solution to decrease loss of tissue, obtain more rapid wound closure and decrease scarring in support of the Naval Medical Research Center, Silver Spring, MD Award Notice · Posted Aug 26, 2015
- Cell-based Wound Therapeutics Award Notice · Posted Dec 6, 2012
- Contract value 100% obligated
- $53,076,259.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost No Fee
- Place of performance
- ARSENAL, PA 15201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $1,650,000 | |
| Supplemental Agreement for work within scope | $8,005,000 | |
| Exercise an Option | $1,592,540 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Supplemental Agreement for work within scope | -$102,600 | |
| Funding Only Action | $1,743,909 | |
| Supplemental Agreement for work within scope | $9,370,876 | |
| Supplemental Agreement for work within scope | $540,000 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $9,894,778 | |
| Funding Only Action | $107,000 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $9,983,691 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $822,065 | |
| Original award | $9,469,000 |
Show all 20
Quick answers
Who was awarded contract N6264513C4014?
N6264513C4014 was awarded to Noveome Biotherapeutics Inc. by Bureau of Medicine and Surgery (Department of the Navy) on April 19, 2013.
How much is contract N6264513C4014 worth?
The government has obligated $53,076,259 on N6264513C4014.
Was contract N6264513C4014 competed?
The extent of competition for N6264513C4014 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award